ERBB2 and breast carcinoma: Routine immunohistochemistry (IHC) diagnostic tests have shown that the expression of Her2 antigen on the surface of breast cancer cells correlates with cancer progression and typically ranges from 5 to 23 × 105 molecules per cell.